The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sevelamer-Global Market Insights and Sales Trends 2025
Synopsis
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
The global Sevelamer market size is expected to reach US$ 337.1 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sevelamer in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Sevelamer market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Suspension segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sevelamer market, driven by demand from China, the second largest economy with some signs of stabilising, the Sevelamer market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sevelamer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sevelamer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sevelamer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sevelamer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sevelamer covered in this report include Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma and Amneal Pharmaceuticals, etc.
The global Sevelamer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Global Sevelamer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sevelamer market, Segment by Type:
Tablet
Oral Suspension
Global Sevelamer market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sevelamer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sevelamer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
The global Sevelamer market size is expected to reach US$ 337.1 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Sevelamer in various end use industries. The expanding demands from the Adult and Pediatric, are propelling Sevelamer market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral Suspension segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Sevelamer market, driven by demand from China, the second largest economy with some signs of stabilising, the Sevelamer market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sevelamer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sevelamer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sevelamer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sevelamer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sevelamer covered in this report include Sanofi, Impax Laboratories, InvaGen Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma and Amneal Pharmaceuticals, etc.
The global Sevelamer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Impax Laboratories
InvaGen Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Amneal Pharmaceuticals
Global Sevelamer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sevelamer market, Segment by Type:
Tablet
Oral Suspension
Global Sevelamer market, by Application
Adult
Pediatric
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sevelamer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sevelamer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Sevelamer Market Overview
1.1 Sevelamer Product Overview
1.2 Sevelamer Market Segment by Type
1.2.1 Tablet
1.2.2 Oral Suspension
1.3 Global Sevelamer Market Size by Type
1.3.1 Global Sevelamer Market Size Overview by Type (2018-2029)
1.3.2 Global Sevelamer Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sevelamer Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sevelamer Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sevelamer Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sevelamer Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sevelamer Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sevelamer Sales Breakdown by Type (2018-2023)
2 Global Sevelamer Market Competition by Company
2.1 Global Top Players by Sevelamer Sales (2018-2023)
2.2 Global Top Players by Sevelamer Revenue (2018-2023)
2.3 Global Top Players by Sevelamer Price (2018-2023)
2.4 Global Top Manufacturers Sevelamer Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sevelamer Market Competitive Situation and Trends
2.5.1 Sevelamer Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sevelamer Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sevelamer as of 2022)
2.7 Date of Key Manufacturers Enter into Sevelamer Market
2.8 Key Manufacturers Sevelamer Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sevelamer Status and Outlook by Region
3.1 Global Sevelamer Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sevelamer Historic Market Size by Region
3.2.1 Global Sevelamer Sales in Volume by Region (2018-2023)
3.2.2 Global Sevelamer Sales in Value by Region (2018-2023)
3.2.3 Global Sevelamer Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sevelamer Forecasted Market Size by Region
3.3.1 Global Sevelamer Sales in Volume by Region (2024-2029)
3.3.2 Global Sevelamer Sales in Value by Region (2024-2029)
3.3.3 Global Sevelamer Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sevelamer by Application
4.1 Sevelamer Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.2 Global Sevelamer Market Size by Application
4.2.1 Global Sevelamer Market Size Overview by Application (2018-2029)
4.2.2 Global Sevelamer Historic Market Size Review by Application (2018-2023)
4.2.3 Global Sevelamer Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Sevelamer Sales Breakdown by Application (2018-2023)
4.3.2 Europe Sevelamer Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Sevelamer Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Sevelamer Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Sevelamer Sales Breakdown by Application (2018-2023)
5 North America Sevelamer by Country
5.1 North America Sevelamer Historic Market Size by Country
5.1.1 North America Sevelamer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sevelamer Sales in Volume by Country (2018-2023)
5.1.3 North America Sevelamer Sales in Value by Country (2018-2023)
5.2 North America Sevelamer Forecasted Market Size by Country
5.2.1 North America Sevelamer Sales in Volume by Country (2024-2029)
5.2.2 North America Sevelamer Sales in Value by Country (2024-2029)
6 Europe Sevelamer by Country
6.1 Europe Sevelamer Historic Market Size by Country
6.1.1 Europe Sevelamer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sevelamer Sales in Volume by Country (2018-2023)
6.1.3 Europe Sevelamer Sales in Value by Country (2018-2023)
6.2 Europe Sevelamer Forecasted Market Size by Country
6.2.1 Europe Sevelamer Sales in Volume by Country (2024-2029)
6.2.2 Europe Sevelamer Sales in Value by Country (2024-2029)
7 Asia-Pacific Sevelamer by Region
7.1 Asia-Pacific Sevelamer Historic Market Size by Region
7.1.1 Asia-Pacific Sevelamer Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sevelamer Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sevelamer Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sevelamer Forecasted Market Size by Region
7.2.1 Asia-Pacific Sevelamer Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sevelamer Sales in Value by Region (2024-2029)
8 Latin America Sevelamer by Country
8.1 Latin America Sevelamer Historic Market Size by Country
8.1.1 Latin America Sevelamer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sevelamer Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sevelamer Sales in Value by Country (2018-2023)
8.2 Latin America Sevelamer Forecasted Market Size by Country
8.2.1 Latin America Sevelamer Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sevelamer Sales in Value by Country (2024-2029)
9 Middle East and Africa Sevelamer by Country
9.1 Middle East and Africa Sevelamer Historic Market Size by Country
9.1.1 Middle East and Africa Sevelamer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sevelamer Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sevelamer Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sevelamer Forecasted Market Size by Country
9.2.1 Middle East and Africa Sevelamer Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sevelamer Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Sevelamer Products Offered
10.1.5 Sanofi Recent Development
10.2 Impax Laboratories
10.2.1 Impax Laboratories Company Information
10.2.2 Impax Laboratories Introduction and Business Overview
10.2.3 Impax Laboratories Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Impax Laboratories Sevelamer Products Offered
10.2.5 Impax Laboratories Recent Development
10.3 InvaGen Pharmaceuticals
10.3.1 InvaGen Pharmaceuticals Company Information
10.3.2 InvaGen Pharmaceuticals Introduction and Business Overview
10.3.3 InvaGen Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.3.4 InvaGen Pharmaceuticals Sevelamer Products Offered
10.3.5 InvaGen Pharmaceuticals Recent Development
10.4 Dr. Reddy's Laboratories
10.4.1 Dr. Reddy's Laboratories Company Information
10.4.2 Dr. Reddy's Laboratories Introduction and Business Overview
10.4.3 Dr. Reddy's Laboratories Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Dr. Reddy's Laboratories Sevelamer Products Offered
10.4.5 Dr. Reddy's Laboratories Recent Development
10.5 Aurobindo Pharma
10.5.1 Aurobindo Pharma Company Information
10.5.2 Aurobindo Pharma Introduction and Business Overview
10.5.3 Aurobindo Pharma Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Aurobindo Pharma Sevelamer Products Offered
10.5.5 Aurobindo Pharma Recent Development
10.6 Amneal Pharmaceuticals
10.6.1 Amneal Pharmaceuticals Company Information
10.6.2 Amneal Pharmaceuticals Introduction and Business Overview
10.6.3 Amneal Pharmaceuticals Sevelamer Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amneal Pharmaceuticals Sevelamer Products Offered
10.6.5 Amneal Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sevelamer Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sevelamer Industrial Chain Analysis
11.4 Sevelamer Market Dynamics
11.4.1 Sevelamer Industry Trends
11.4.2 Sevelamer Market Drivers
11.4.3 Sevelamer Market Challenges
11.4.4 Sevelamer Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sevelamer Distributors
12.3 Sevelamer Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
